172 related articles for article (PubMed ID: 34770805)
1. Utilization of Sodium Nitroprusside as an Intestinal Permeation Enhancer for Lipophilic Drug Absorption Improvement in the Rat Proximal Intestine.
Kishimoto H; Miyazaki K; Tedzuka H; Ozawa R; Kobayashi H; Shirasaka Y; Inoue K
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770805
[TBL] [Abstract][Full Text] [Related]
2. Sodium Nitroprusside Enhances Absorption in the Rat Jejunum via the Transcellular Route.
Takizawa Y; Tobe Y; Sakamoto N; Sakamoto J; Hayashi M
J Membr Biol; 2020 Jun; 253(3):221-228. PubMed ID: 32328687
[TBL] [Abstract][Full Text] [Related]
3. Absorption-Enhancing Effect of Nitric Oxide on the Absorption of Hydrophobic Drugs in Rat Duodenum.
Kishimoto H; Miyazaki K; Takizawa Y; Shirasaka Y; Inoue K
J Pharm Sci; 2016 Feb; 105(2):729-733. PubMed ID: 26458075
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of reversible absorption-enhancing effect of sodium nitroprusside in rat small intestine.
Takizawa Y; Kishimoto H; Kitazato T; Ishizaka H; Kamiya N; Ito Y; Tomita M; Hayashi M
Eur J Pharm Sci; 2013 Jul; 49(4):664-70. PubMed ID: 23707468
[TBL] [Abstract][Full Text] [Related]
5. Mucins are Involved in the Intestinal Permeation of Lipophilic Drugs in the Proximal Region of Rat Small Intestine.
Miyazaki K; Kishimoto H; Muratani M; Kobayashi H; Shirasaka Y; Inoue K
Pharm Res; 2019 Sep; 36(11):162. PubMed ID: 31529336
[TBL] [Abstract][Full Text] [Related]
6. Effects of pharmaceutical excipients on membrane permeability in rat small intestine.
Takizawa Y; Kishimoto H; Nakagawa M; Sakamoto N; Tobe Y; Furuya T; Tomita M; Hayashi M
Int J Pharm; 2013 Sep; 453(2):363-70. PubMed ID: 23742974
[TBL] [Abstract][Full Text] [Related]
7. Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes.
Lacombe O; Woodley J; Solleux C; Delbos JM; Boursier-Neyret C; Houin G
Eur J Pharm Sci; 2004 Dec; 23(4-5):385-91. PubMed ID: 15567292
[TBL] [Abstract][Full Text] [Related]
8. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
Schipper NG; Vârum KM; Stenberg P; Ocklind G; Lennernäs H; Artursson P
Eur J Pharm Sci; 1999 Aug; 8(4):335-43. PubMed ID: 10425384
[TBL] [Abstract][Full Text] [Related]
9. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
[TBL] [Abstract][Full Text] [Related]
10. Sodium nitroprusside stimulates anion secretion and inhibits sodium chloride absorption in rat colon.
Wilson KT; Xie Y; Musch MW; Chang EB
J Pharmacol Exp Ther; 1993 Jul; 266(1):224-30. PubMed ID: 8331560
[TBL] [Abstract][Full Text] [Related]
11. Improvement of intestinal absorption of macromolecules by nitric oxide donor.
Numata N; Takahashi K; Mizuno N; Utoguchi N; Watanabe Y; Matsumoto M; Mayumi T
J Pharm Sci; 2000 Oct; 89(10):1296-304. PubMed ID: 10980504
[TBL] [Abstract][Full Text] [Related]
12. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
[TBL] [Abstract][Full Text] [Related]
13. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes.
Yamamoto A; Okagawa T; Kotani A; Uchiyama T; Shimura T; Tabata S; Kondo S; Muranishi S
J Pharm Pharmacol; 1997 Nov; 49(11):1057-61. PubMed ID: 9401937
[TBL] [Abstract][Full Text] [Related]
14. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.
Yamamoto A; Tatsumi H; Maruyama M; Uchiyama T; Okada N; Fujita T
J Pharmacol Exp Ther; 2001 Jan; 296(1):84-90. PubMed ID: 11123366
[TBL] [Abstract][Full Text] [Related]
15. Effect of prolonged omeprazole administration on segmental intestinal Mg
Suksridechacin N; Kulwong P; Chamniansawat S; Thongon N
World J Gastroenterol; 2020 Mar; 26(11):1142-1155. PubMed ID: 32231419
[TBL] [Abstract][Full Text] [Related]
16. Permeability and absorption of leuprolide from various intestinal regions in rabbits and rats.
Zheng Y; Qiu Y; Lu MF; Hoffman D; Reiland TL
Int J Pharm; 1999 Aug; 185(1):83-92. PubMed ID: 10425368
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide modulates epithelial permeability in the feline small intestine.
Kubes P
Am J Physiol; 1992 Jun; 262(6 Pt 1):G1138-42. PubMed ID: 1616043
[TBL] [Abstract][Full Text] [Related]
18. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic analysis for drug permeation through intestinal membrane.
Hayashi M; Tomita M
Drug Metab Pharmacokinet; 2007 Apr; 22(2):67-77. PubMed ID: 17495413
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.
Lv XY; Li J; Zhang M; Wang CM; Fan Z; Wang CY; Chen L
AAPS PharmSciTech; 2010 Mar; 11(1):372-82. PubMed ID: 20237966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
